Targeting of epigenetic regulators in neuroblastoma-Reference-Cited by-同舟云学术

Targeting of epigenetic regulators in neuroblastoma

Published:2018-04 Issue:4 Volume:50 Page:1-12
ISSN:1226-3613
Container-title:Experimental & Molecular Medicine
language:en
Short-container-title:Exp Mol Med

Author:

Jubierre Luz,Jiménez Carlos,Rovira Eric,Soriano Aroa,Sábado Constantino,Gros Luis,Llort Anna,Hladun Raquel,Roma Josep,Toledo Josep Sánchez de,Gallego Soledad,Segura Miguel F.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

https://www.nature.com/articles/s12276-018-0077-2.pdf

Reference151 articles.

1. DeVita, V. T. & Rosenberg, S. A. Two hundred years of cancer research. N. Engl. J. Med 23, 2207–2214 (2012).

2. Khamisipour, G., Jadidi-Niaragh, F., Jahromi, A. S., Zandi, K. & Hojjat-Farsangi, M. Mechanisms of tumor cell resistance to the current targeted-therapy agents. Tumor Biol. 37, 10021–10039 (2016).

3. Shi, V. J., Levy, L. L. & Choi, J. N. Cutaneous manifestations of nontargeted and targeted chemotherapies. Semin Oncol. 43, 419–425 (2016).

4. Ezoe, S. Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor. Int J. Environ. Res. Public Health 9, 2444–2453 (2012).

5. Pàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H. & Viñals, F. et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220–231 (2009).

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYCN in neuroblastoma: The kings' new clothes and drugs;EJC Paediatric Oncology;2024-12

2. Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma;JCI Insight;2024-07-22

3. Histone Deacetylases in Retinoblastoma;International Journal of Molecular Sciences;2024-06-24

4. Encapsulation of 4-oxo-N-(4-hydroxyphenyl) retinamide in human serum albumin nanoparticles promotes EZH2 degradation in preclinical neuroblastoma models;Nanoscale;2024

5. Neuroblastoma Epigenetic Landscape: Drugging Opportunities;Pediatric Oncology;2024